经颈动脉血运重建与颈动脉内膜剥脱术在患者风险状态不同时结局相似
回顾性分析2015至2020年血管质量倡议中124531例颈动脉血运重建患者,比较颈动脉内膜剥脱术(CEA)、经股动脉颈动脉支架置入术(TFCAS)和经颈动脉血运重建(TCAR)的围手术期结局。在高风险患者中,TCAR较CEA的围手术期卒中调整比值比更低(aOR 0.82,95%CI 0.68-0.99),在标准风险患者中两者相似(aOR 1.05,95%CI 0.84-1.31);TFCAS较CEA的卒中调整比值比在高风险和标准风险患者中均更高。
要点
- 高风险患者围手术期卒中发生率:CEA 2.7%、TFCAS 3.4%、TCAR 2.4%(P < .001)。
- 标准风险患者围手术期卒中发生率:CEA 1.7%、TFCAS 2.7%、TCAR 1.8%(P < .001)。
- TFCAS和TCAR患者心肌梗死调整比值比均显著低于CEA患者(均P < .001)。
核心结论
- 高风险患者中CEA、TFCAS和TCAR的围手术期风险支持现行CMS标准,但标准风险患者中各血运重建方式的风险提示区分TCAR与TFCAS可能是合理的。
研究设计与样本
- 回顾性分析血管质量倡议中2015至2020年接受颈动脉血运重建的患者,按是否满足CMS颈动脉支架置入术标准分层,采用单因素和多因素logistic回归分析。
- 共纳入124531例患者,其中CEA 91687例(73.6%)、TFCAS 17247例(13.9%)、TCAR 15597例(12.5%)。
主要发现
- 高风险患者围手术期卒中发生率:CEA 2.7%、TFCAS 3.4%、TCAR 2.4%(P < .001)。
- 标准风险患者围手术期卒中发生率:CEA 1.7%、TFCAS 2.7%、TCAR 1.8%(P < .001)。
- 调整基线人口学和临床特征后,高风险患者中TCAR较CEA的围手术期卒中调整比值比更低(aOR 0.82,95%CI 0.68-0.99),标准风险患者中两者相似(aOR 1.05,95%CI 0.84-1.31)。
- TFCAS较CEA的围手术期卒中调整比值比在高风险患者中更高(aOR 1.23,95%CI 1.03-1.46),在标准风险患者中也更高(aOR 1.60,95%CI 1.37-1.86)。
- 两种风险状态人群中,TFCAS和TCAR患者心肌梗死的调整比值比均显著低于CEA患者(均P < .001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Carotid artery stenting (CAS), including both transfemoral carotid artery stenting (TFCAS) and transcarotid artery revascularization (TCAR), reimbursement has been limited to high-risk patients by the Centers for Medicare & Medicaid Services (CMS) since 2005. We aimed to assess the association of CMS high-risk status with perioperative outcomes for carotid endarterectomy (CEA), TFCAS, and TCAR. METHODS: We performed a retrospective review of all Vascular Quality Initiative patients who underwent carotid revascularization between 2015 and 2020. Patients were stratified by whether they met CMS CAS criteria, and univariable and multivariable logistic regression analyses were performed to assess the association of procedure type (CEA, TFCAS, TCAR) with perioperative outcomes. RESULTS: Of 124,531 individuals who underwent carotid revascularization procedures, 91,687 (73.6%) underwent CEA, 17,247 (13.9%) underwent TFCAS, and 15,597 (12.5%) underwent TCAR. Among patients who met the CMS CAS criteria (ie, high-risk patients), the incidence of perioperative stroke was 2.7% for CEA, 3.4% for TFCAS, and 2.4% for TCAR (P < .001). Among standard-risk patients, the incidence of perioperative stroke was 1.7% for CEA, 2.7% for TFCAS, and 1.8% for TCAR (P < .001). After adjusting for baseline demographic and clinical characteristics, the odds of perioperative stroke were lower for TCAR versus CEA in high-risk patients (adjusted odds ratio [aOR], 0.82; 95% confidence interval [CI], 0.68-0.99) and similar in standard-risk patients (aOR, 1.05; 95% CI, 0.84, 1.31). In contrast, the adjusted odds of perioperative stroke were higher for TFCAS versus CEA in high-risk patients (aOR, 1.23; 95% CI, 1.03-1.46) and standard-risk patients (aOR, 1.60; 95% CI, 1.37-1.86). In both populations, TFCAS and TCAR patients had significantly lower odds of myocardial infarction than CEA patients (both P < .001). CONCLUSIONS: The perioperative risks associated with CEA, TFCAS, and TCAR in high-risk patients support the current CMS criteria, although the risks associated with each revascularization approach in standard-risk patients suggest that distinguishing TCAR from TFCAS may be warranted.
引用
- Zhang GQ, Bose S, Stonko DP, et al. Transcarotid artery revascularization is associated with similar outcomes to carotid endarterectomy regardless of patient risk status. J Vasc Surg. 2022. PMID: 35367564. doi:10.1016/j.jvs.2022.03.860
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。